Brief: Cosmo Pharmaceuticals Announces U.S. FDA Approval Of Byfavo(Tm)

Cosmo NV

02/07/2020 19:11

July 2 (Reuters) - Cosmo Pharmaceuticals NV  COPN.S :
    * COSMO PHARMACEUTICALS ANNOUNCES US FDA APPROVAL OF
BYFAVO(TM)
(REMIMAZOLAM INJECTION) FOR THE INDUCTION AND MAINTENANCE OF
PROCEDURAL SEDATION  COPN.S 
    * COSMO PHARMACEUTICALS NV - ANNOUNCED TODAY APPROVAL OF
BYFAVOTM
IN U.S. FOR PROCEDURAL SEDATION IN ADULT PATIENTS

Source text for Eikon:  ID:nTENfik5oa 
Further company coverage:  COPN.S 

 ((Reuters.Briefs@thomsonreuters.com;))